Apeloa Pharmaceutical (SHE:000739) signed a strategic cooperation framework agreement with Jitai Technology Beijing to collaborate on contract development and manufacturing organization (CDMO) services and related projects.
The five-year partnership positions Apeloa as the preferred CDMO provider for Jitai and its affiliates, while exploring new project companies and joint investments, according to a Tuesday filing with the Shenzhen bourse.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments